<DOC>
	<DOCNO>NCT01719497</DOCNO>
	<brief_summary>The aim present study conduct human trial [ C-11 ] OMAR , new PET imaging agent brain cannabinoid type 1 receptor ( CB1 ) , determine pharmacokinetics bind characteristic .</brief_summary>
	<brief_title>Imaging Cannabinoid 1 Receptors Using 11COMAR PET</brief_title>
	<detailed_description>This pilot , 2-part study ass kinetics radioactivity medically healthy subject , subject alcohol dependency ( AD ) , obese subject follow intravenous administration image agent [ C-11 ] OMAR .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<criteria>1 . Are overtly healthy male female ( AD obesity ) , determine medical history physical examination . Males females stable medical problem , investigator 's opinion , significantly alter disposition drug , place subject increase risk participate study , interfere interpretation data . 2 . Are age 18 65 year , inclusive . 3 . Have clinical laboratory test result within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator . ( Note : specific laboratory test list section 3.4 ) 4 . Have arterial access sufficient allow blood sample per protocol . 5 . Are reliable willing make available duration study willing follow study procedure . 6 . Have give write informed consent approve ethical review board govern site . 1 . Are currently enrol , discontinue within last [ 30 day ] , clinical trial involve offlabel use investigational drug device , concurrently enrol type medical research judge scientifically medically compatible study . 2 . Current substance abuse ( AD ) include marijuana use , severe systemic disease base history physical exam . 3 . Laboratory test clinically significant abnormality positive urine toxicology screen . ( Note : specific laboratory test list section 3.4 ) 4 . Prior participation research protocol last year radiation exposure would exceed annual limit . 5 . Presence ferromagnetic metal body heart pacemaker . 6 . Are person previously complete withdrawn study study investigate [ C11 ] OMAR . 7 . Regularly use know drug abuse ( alcohol ) within 30 day study and/or show positive finding urinary drug screening . 8 . Show evidence human immunodeficiency virus ( HIV ) and/or positive human HIV antibody . 9 . Are woman positive pregnancy test woman lactate . 10 . Have history head trauma prolonged loss consciousness ( &gt; 10 minute ) , neurological condition include stroke seizure ( exclude single childhood febrile seizure ) history migraine headaches 11 . History adverse drug reaction intolerance three type systemically administer medication 12 . Have use prescription medication ( except oral contraceptive hormone replacement therapy ) overthecounter medication ( include herbal remedy diet aid ) within 14 day image session . Multiple vitamin specifically permit 13 . Have implant embed metal object fragment head body would present risk MRI scanning procedure , work ferrous metal either vocation hobby ( example , sheet metal worker , welder , machinist ) way might lead unknown , indwell metal fragment could cause injury move response placement magnetic field 14 . Have exposure ionize radiation combination study tracer would result cumulative exposure exceeds recommend exposure limit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>